Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.

The British journal of dermatology - 1 May 2010

Kasperkiewicz M, Hirose M, Recke A, Schmidt E, Zillikens D, Ludwig R J

Abstract excerpt

BACKGROUND: Epidermolysis bullosa acquisita (EBA) is a severe autoimmune skin disease characterized by autoantibodies to type VII collagen, the major component of anchoring fibrils. In this and other autoimmune bullous dermatoses, specific autoantibody detection systems are not only of diagnostic use but also allow monitoring of circulating and skin-bound autoantibodies during the course of the disease. However,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Collagen Type VII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Complement Activation

Share to Maternal-Fetal Exchange

Share to Microscopy, Fluorescence

Share to Pregnancy

Share to Pregnancy Complications

Source

Identifiers

PMID: 20222918
DOI: 10.1111/j.1365-2133.2010.09680.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.PMID 20222918Read ↗

Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.Semantic proximity Read ↗

Epidermolysis bullosa acquisita: a disease of autoimmunity to type VII collagen.Semantic proximity Read ↗

Systemic Collagen VII Replacement Therapy for Advanced Recessive Dystrophic Epidermolysis BullosaSemantic proximity Read ↗

Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.Semantic proximity Read ↗

Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita.Semantic proximity Read ↗

Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype.Semantic proximity Read ↗

Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters.Semantic proximity Read ↗

IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.Semantic proximity Read ↗

Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.Semantic proximity Read ↗

Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa.Semantic proximity Read ↗

A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.Semantic proximity Read ↗

Injection of Recombinant Human Type VII Collagen Corrects the Disease Phenotype in a Murine Model of Dystrophic Epidermolysis BullosaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.